Johnson & Johnson is buying cancer drug biotech Firefly Bio for $1 billion

石英财经（Quartz），Quartz（石英财经），面向变革的全球新经济指南，报道商业、金融、科技与生活方式。关注

The deal targets KRAS-driven tumors, which J&J says have limited treatment options and survival measured in months

添加评论
点赞收藏
点踩分享查看原文
评论
?
参与讨论